Voloridge Investment Management, LLC Apellis Pharmaceuticals, Inc. Transaction History
Voloridge Investment Management, LLC
- $26.2 Billion
- Q2 2024
A detailed history of Voloridge Investment Management, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 689,108 shares of APLS stock, worth $20.6 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
689,108Holding current value
$20.6 Million% of portfolio
0.1%Shares
16 transactions
Others Institutions Holding APLS
# of Institutions
299Shares Held
113MCall Options Held
5.21MPut Options Held
691K-
Wellington Management Group LLP Boston, MA16.4MShares$489 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$346 Million15.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$332 Million5.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$293 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$173 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.28B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...